Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
about
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Identification of new oral dos ...... e and severe renal impairment.
@en
Identification of new oral dos ...... e and severe renal impairment.
@nl
type
label
Identification of new oral dos ...... e and severe renal impairment.
@en
Identification of new oral dos ...... e and severe renal impairment.
@nl
prefLabel
Identification of new oral dos ...... e and severe renal impairment.
@en
Identification of new oral dos ...... e and severe renal impairment.
@nl
P2093
P2860
P356
P1476
Identification of new oral dos ...... e and severe renal impairment.
@en
P2093
Barbara J Brennan
Craig R Rayner
Mohamed A Kamal
Nicolas Frey
Peter N Morcos
Vishak Subramoney
Yi Ting Kayla Lien
P2860
P304
P356
10.1002/CPDD.203
P577
2015-07-02T00:00:00Z